BioMed Research International / 2022 / Article / Tab 5 / Research Article
Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis Table 5 Spearman’s rank correlations between the serum concentrations of CXCL-8, CEA, and CA19-9 and the clinicopathological characteristics among patients with colorectal cancer.
TNM stage T stage N stage M stage Tumor size Histological grade Vascular invasion Nerve invasion CEA CA19-9 CXCL-8 TNM stage 1.000 0.678 0.875 0.456 0.085 0.146 -0.151 -0.274 0.265 0.136 0.075 <0.001 <0.001 <0.001 0.102 0.014 0.012 <0.001 <0.001 0.021 0.131 T stage 0.678 1.000 0.446 0.324 0.158 0.207 -0.114 -0.319 0.244 0.139 0.048 <0.001 <0.001 <0.001 0.009 0.001 0.044 <0.001 <0.001 0.018 0.237 N stage 0.875 0.446 1.000 0.400 -0.044 0.143 -0.128 -0.179 0.186 0.104 0.037 <0.001 <0.001 <0.001 0.257 0.016 0.027 0.003 0.002 0.060 0.290 M stage 0.456 0.324 0.400 1.000 0.029 0.109 -0.084 -0.097 0.277 0.181 0.117 <0.001 <0.001 <0.001 0.334 0.050 0.103 0.072 <0.001 0.003 0.039 Tumor size 0.085 0.158 -0.044 0.029 1.000 0.093 -0.012 -0.188 0.173 0.070 0.122 0.102 0.009 0.257 0.334 0.080 0.431 0.002 0.005 0.148 0.034 Histological Grade 0.146 0.207 0.143 0.109 0.093 1.000 0.099 -0.055 0.064 0.125 0.001 0.014 0.001 0.016 0.050 0.080 0.069 0.204 0.168 0.030 0.493 Vascular invasion -0.151 -0.114 -0.128 -0.084 -0.012 0.099 1.000 0.231 -0.046 -0.055 0.028 0.012 0.044 0.027 0.103 0.431 0.069 <0.001 0.247 0.203 0.335 Nerve invasion -0.274 -0.319 -0.179 -0.097 -0.188 -0.055 0.231 1.000 -0.202 -0.118 -0.067 <0.001 <0.001 0.003 0.072 0.002 0.204 <0.001 0.001 0.039 0.159 CEA 0.265 0.244 0.186 0.277 0.173 0.064 -0.046 -0.202 1.000 0.423 0.015 <0.001 <0.001 0.002 <0.001 0.005 0.168 0.247 0.001 <0.001 0.409 CA19-9 0.136 0.139 0.104 0.181 0.070 0.125 -0.055 -0.118 0.423 1.000 -0.001 0.021 0.018 0.060 0.003 0.148 0.030 0.203 0.039 <0.001 0.491 CXCL-8 0.075 0.048 0.037 0.117 0.122 0.001 0.028 -0.067 0.015 -0.001 1.000 0.131 0.237 0.290 0.039 0.034 0.493 0.335 0.159 0.409 0.491